Results 61 to 70 of about 2,666 (203)
Meige′s syndrome: Rare neurological disorder presenting as conversion disorder
Indian Journal of Psychological Medicine, 2013 Meige′s syndrome is a rare neurological syndrome characterized by oromandibular dystonia and blepharospasm. Its pathophysiology is not clearly determined.
Mohapatra Debadatta, Ajay K Mishra
doaj +1 more source
Dystonic opisthotonus: A "red flag" for neurodegeneration with brain iron accumulation syndromes? [PDF]
, 2013 Back arching was reported in one of the very first patients with neurodegeneration with brain iron accumulation syndrome (NBIAs) published in 1936. However, recent reports have mainly focused on the genetic and imaging aspects of these disorders, and the
Aggarwal, A +9 more
core
Treatment of masseteric hypertrophy with botulinum toxin : a report of two cases [PDF]
, 2010 Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek.
Bas, Burcu +3 more
core +1 more source
Oromandibular Dystonia—Meige′s Syndrome: Report of a Rare Case with Review
Journal of Indian Academy of Oral Medicine and Radiology, 2010 Meige′s syndrome is a combination of two forma of dystonia; blepharospasm and oromandibular dystonia (OMD). Oromandibular dystonia (OMD) is a form of focal dystonia affecting head and neck region, including the lower face, jaw, tongue and larynx.
Siddharth Gupta, Basavaraj T Bhagwati
doaj
Essential blepharospasm: literature review [PDF]
, 2010 O blefaroespasmo essencial é uma distonia focal caracterizada por contrações involuntárias, espasmódicas e bilaterais dos músculos orbicular da pálpebra, corrugador, prócerus e depressor do supercílio.
AOKI, Lísia +3 more
core +2 more sources
Oromandibular dystonia secondary to methylphenidate: A case report and literature review
International Archives of Health Sciences, 2020 Methylphenidate (MTP) is a first-line treatment for attention-deficit hyperactivity disorder (ADHD) in children and adults and as a second-line treatment for narcolepsy in adults.
Jamir Pitton Rissardo +1 more
doaj +1 more source
Clinical Relevance of Botulinum Toxin Immunogenicity [PDF]
, 2012 Botulinum toxin type A is a 150 kD protein produced by Clostridium botulinum, which exists in a complex with up to six additional proteins. The ability of botulinum toxin to inhibit acetylcholine release at the neuromuscular junction has been exploited ...
Reiner Benecke
core +1 more source
Movement Disorders, EarlyView.D2 receptor ablation in indirect‐pathway striatal neurons reduces or abolishes dyskinetic and dystonic behaviors induced by L‐DOPA or D2 receptor agonists, respectively. Contralateral turning is reduced, while forward locomotion is increased. These effects are associated with modulation of neuronal activity in dorsal striatum and external globus ...
Laura Andreoli +5 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 4, April 2026.Partial cranial nerve radiofrequency ablation (RFA) represents a feasible and potentially effective salvage therapy for Primary Meige Syndrome following deep brain stimulation (DBS) failure. Targeting peripheral pathways may facilitate rapid symptom remission with manageable sequelae, offering a practical alternative when central neuromodulation proves
Xue Li +6 more
wiley +1 more source
Multiple system atrophy associated with Meige syndrome: A rare case report
Radiology Case Reports, 2023 Multiple system atrophy (MSA) is a rare form of adult-onset α-synucleinopathy. Meige syndrome, identified as bilateral blepharospasm and oromandibular dystonia, is a type of focal dystonic movement disorder.
Jiaji Liang, MD +2 more
doaj +1 more source